PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29532488-0	2018	Clinical-scale production of cGMP compliant CD3/CD19 cell-depleted NK cells in the evolution of NK cell immunotherapy at a single institution.	Cyclic GMP	29-33	CD19 molecule	Homo sapiens	48-52	
34997202-0	2022	Development of a cGMP-compliant process to manufacture donor-derived, CD45RA-depleted memory CD19-CAR T cells.	Cyclic GMP	17-21	CD19 molecule	Homo sapiens	93-97	
23407473-8	2013	In this report, we demonstrate the procedures that can be undertaken in compliance with cGMP to generate CD19-specific CAR(+) T cells suitable for human application.	Cyclic GMP	88-92	CD19 molecule	Homo sapiens	105-109	
29532488-13	2018	CONCLUSION: Clinical-scale/cGMP production of NK cells using CD3/CD19 cell-depletion effectively minimized T-cell and B-cell contamination in a single manipulation without compromise to NK-cell recovery.	Cyclic GMP	27-31	CD19 molecule	Homo sapiens	65-69